Reframing relations with Pharma

Voluntarism is not enough

BMJ 2009; 338 doi: 10.1136/bmj.b762 (Published 24 February 2009)
Cite this as: BMJ 2009;338:b762

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. John H Noble Jr, retired endowed professor for social justice, Catholic University of America, Washington, DC1
  1. 1Georgetown, TX 78633, USA
  1. jhnoble{at}verizon.net

    Krumholz and Ross’s six recommendations to regulate the pharmaceutical industry make sense but do not go far enough to assure compliance.1 They are much too dependent on the voluntarism of …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL